CQS
EW icon

Credential Qtrade Securities’s Edwards Lifesciences EW Stock Holding History

Credential Qtrade Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$9.46K Sell
99
-55
-36% -$4.62K ﹤0.01% 301
2023
Q4 		$11.7K Buy
154
+55
+56% +$3.83K ﹤0.01% 286
2023
Q3 		$6.86K Hold
99
– – ﹤0.01% 286
2023
Q2 		$9.34K Sell
99
-27
-21% -$2.35K ﹤0.01% 288
2023
Q1 		$10.4K Buy
+126
New +$9.9K ﹤0.01% 292

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Credential Qtrade Securities's EW Position: Q1 2024 in Review

Credential Qtrade Securities reduced its Edwards Lifesciences (EW) stake by 36% in Q1 2024, selling an estimated $4.62K and leaving 99 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Credential Qtrade Securities first reported a position in EW in Q1 2023 and has held it in 5 quarters since. The position peaked at $11.7K in Q4 2023. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Credential Qtrade Securities held 99 shares of Edwards Lifesciences worth $9.46K as of Q1 2024.
  • Credential Qtrade Securities sold 55 Edwards Lifesciences shares in Q1 2024, an estimated $4.62K.
  • Edwards Lifesciences made up ﹤0.01% of Credential Qtrade Securities's portfolio in Q1 2024, its #301 holding.
  • Credential Qtrade Securities first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 5 quarters since.
  • Credential Qtrade Securities's Edwards Lifesciences position peaked at $11.7K in Q4 2023.
  • 1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.